| The validation of surrogate endpoints in meta-analyses of randomized experiments M Buyse, G Molenberghs, T Burzykowski, D Renard, H Geys Biostatistics 1 (1), 49-67, 2000 | 679 | 2000 |
| Validation of surrogate end points in multiple randomized clinical trials with failure time end points T Burzykowski, G Molenberghs, M Buyse, H Geys, D Renard Journal of the Royal Statistical Society Series C: Applied Statistics 50 (4 …, 2001 | 274 | 2001 |
| Antibiotic prescribing for acute cough: the effect of perceived patient demand S Coenen, B Michiels, D Renard, J Denekens, P Van Royen British Journal of General Practice 56 (524), 183-190, 2006 | 245 | 2006 |
| Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders TE Wilens, LA Adler, MD Weiss, D Michelson, JL Ramsey, RJ Moore, ... Drug and alcohol dependence 96 (1-2), 145-154, 2008 | 239 | 2008 |
| Multilevel modeling of complex survey data T Asparouhov, B Muthén Proceedings of the joint statistical meeting in Seattle, 2718-2726, 2006 | 217 | 2006 |
| Omalizumab decreases IgE production in patients with allergic (IgE‐mediated) asthma; PKPD analysis of a biomarker, total IgE PJ Lowe, D Renard British journal of clinical pharmacology 72 (2), 306-320, 2011 | 168 | 2011 |
| Statistical challenges in the evaluation of surrogate endpoints in randomized trials G Molenberghs, M Buyse, H Geys, D Renard, T Burzykowski, A Alonso Controlled Clinical Trials 23 (6), 607-625, 2002 | 144 | 2002 |
| A pairwise likelihood approach to estimation in multilevel probit models D Renard, G Molenberghs, H Geys Computational Statistics & Data Analysis 44 (4), 649-667, 2004 | 138 | 2004 |
| Applying concepts of generalizability theory on clinical trial data to investigate sources of variation and their impact on reliability T Vangeneugden, A Laenen, H Geys, D Renard, G Molenberghs Biometrics 61 (1), 295-304, 2005 | 111 | 2005 |
| Effects of soft drink and table beer consumption on insulin response in normal teenagers and carbohydrate drink in youngsters JP Janssens, N Shapira, P Debeuf, L Michiels, R Putman, L Bruckers, ... European journal of cancer prevention 8 (4), 289-296, 1999 | 109 | 1999 |
| Applying linear mixed models to estimate reliability in clinical trial data with repeated measurements T Vangeneugden, A Laenen, H Geys, D Renard, G Molenberghs Controlled clinical trials 25 (1), 13-30, 2004 | 96 | 2004 |
| Prentice's approach and the meta-analytic paradigm: a reflection on the role of statistics in the evaluation of surrogate endpoints A Alonso, G Molenberghs, T Burzykowski, D Renard, H Geys, Z Shkedy, ... Biometrics 60 (3), 724-728, 2004 | 81 | 2004 |
| Validation of surrogate endpoints in multiple randomized clinical trials with discrete outcomes D Renard, H Geys, G Molenberghs, T Burzykowski, M Buyse Biometrical Journal: Journal of Mathematical Methods in Biosciences 44 (8 …, 2002 | 81 | 2002 |
| Simplified hierarchical linear models for the evaluation of surrogate endpoints F Tibaldi, JC Abrahantes, G Molenberghs, D Renard, T Burzykowski, ... Journal of Statistical Computation and Simulation 73 (9), 643-658, 2003 | 66 | 2003 |
| Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches D Renard, M Looby, B Kramer, D Lawrence, D Morris, DR Stanski Respiratory research 12, 1-9, 2011 | 57 | 2011 |
| Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia M Hendrikx, H Jiang, H Gutermann, J Toelsie, D Renard, A Briersb, ... The Journal of thoracic and cardiovascular surgery 118 (3), 452-459, 1999 | 53 | 1999 |
| Choice of units of analysis and modeling strategies in multilevel hierarchical models JC Abrahantes, G Molenberghs, T Burzykowski, Z Shkedy, AA Abad, ... Computational statistics & data analysis 47 (3), 537-563, 2004 | 45 | 2004 |
| Validation of a longitudinally measured surrogate marker for a time-to-event endpoint D Renard, H Geys, G Molenberghs, T Burzykowski, M Buyse, ... Journal of Applied Statistics 30 (2), 235-247, 2003 | 44 | 2003 |
| Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of … G Flesch, C Czendlik, D Renard, P Lloyd Drug metabolism and disposition 39 (6), 1103-1110, 2011 | 43 | 2011 |
| Reduced sodium transport with nasal administration of the prostasin inhibitor camostat in subjects with cystic fibrosis SM Rowe, G Reeves, H Hathorne, GM Solomon, S Abbi, D Renard, ... Chest 144 (1), 200-207, 2013 | 40 | 2013 |
